The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 15 of 15
Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
NCT00178542
Ambisome in Liver Transplant Patients
NCT00161356
Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2
NCT00135252
Enteral Glutamine Supplementation for the Patient With Major Torso Trauma
NCT00178581
Community Diabetes Education Program Evaluation "Code Evaluation"
NCT00151190
Management of Hyponatremia in Preterm Infants on Diuretics
NCT00156572
Tailored Interactive Intervention to Increase CRCS
NCT01084746
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
NCT00283322
"The Once A Day Protease Inhibitor Regimens"
NCT00242216
Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery
NCT00178633
Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants
NCT00131248
A Randomized, Control Trial for Preinduction Cervical Ripening
NCT00393731
Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
NCT00178620
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
NCT00218348
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
NCT00273754
Comparison of the Video and Macintosh Laryngoscope in Patients Who May be Difficult to Intubate
NCT00178555
Combined Treatment for Cocaine-Alcohol Dependence - 1
NCT00218569
Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief
NCT00435383
Caffeinol Hypothermia Protocol
NCT00299416
Argatroban Stroke Treatment - A Pilot Safety Study
NCT00268762
Tu Salud Si Cuenta Media Campaign
NCT00788879
A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease
NCT00178672
Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students
NCT00161382
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
NCT00178607
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
NCT00178646
Interferon-Alpha for Diabetes Mellitus Type 1
NCT00024518
Intervention for Stroke Survivors and Their Spousal Caregivers
NCT00178529
Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program
NCT00223314
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
NCT00218075
Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
NCT00000447
Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)
NCT00234260
Amphetamine Cocaine Interaction Study - 2
NCT00000305
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.